164 related articles for article (PubMed ID: 35226241)
1. Treatment and outcome of pediatric intracranial ependymoma after first relapse.
Liu ZM; Han Z; Wang JM; Sun T; Liu W; Li B; Gong J; Li CD; Zhao F; Tian YJ
J Neurooncol; 2022 May; 157(3):385-396. PubMed ID: 35226241
[TBL] [Abstract][Full Text] [Related]
2. Survival and Prognostic Factors of Adult Intracranial Ependymoma: A Single-institutional Analysis of 236 Patients.
Zhao F; Wu T; Wang LM; Zhang J; Zhang H; Li SW; Zhang S; Li P; Wang B; Luo L; Liu PN
Am J Surg Pathol; 2021 Jul; 45(7):979-987. PubMed ID: 33739788
[TBL] [Abstract][Full Text] [Related]
3. Timing of adjuvant radiotherapy and treatment outcome in childhood ependymoma.
Liu AP; Shing MM; Yuen HL; Li CH; Ling SC; Luk CW; Ha SY; Li CK; Kwong DL; Chan GC
Pediatr Blood Cancer; 2014 Apr; 61(4):606-11. PubMed ID: 24167035
[TBL] [Abstract][Full Text] [Related]
4. Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.
Benesch M; Mynarek M; Witt H; Warmuth-Metz M; Pietsch T; Bison B; Pfister SM; Pajtler KW; Kool M; Schüller U; Pietschmann K; Juhnke BO; Tippelt S; Fleischhack G; Schmid I; Kramm CM; Vorwerk P; Beilken A; Classen CF; Hernáiz Driever P; Kropshofer G; Imschweiler T; Lemmer A; Kortmann RD; Rutkowski S; von Hoff K
Oncologist; 2019 Sep; 24(9):e921-e929. PubMed ID: 30850560
[TBL] [Abstract][Full Text] [Related]
5. Outcomes after first relapse of childhood intracranial ependymoma.
Tsai JW; Manoharan N; Alexandrescu S; Zimmerman MA; Scully J; Chordas C; Clymer J; Wright KD; Filbin M; Ullrich NJ; Marcus KJ; Haas-Kogan D; Chi SN; Bandopadhayay P; Yeo KK
Pediatr Blood Cancer; 2021 Aug; 68(8):e28930. PubMed ID: 33565268
[TBL] [Abstract][Full Text] [Related]
6. A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups.
Ritzmann TA; Rogers HA; Paine SML; Storer LCD; Jacques TS; Chapman RJ; Ellison D; Donson AM; Foreman NK; Grundy RG
Pediatr Blood Cancer; 2020 Sep; 67(9):e28426. PubMed ID: 32614133
[TBL] [Abstract][Full Text] [Related]
7. Relapsed intracranial ependymoma in children in the UK: patterns of relapse, survival and therapeutic outcome.
Messahel B; Ashley S; Saran F; Ellison D; Ironside J; Phipps K; Cox T; Chong WK; Robinson K; Picton S; Pinkerton CR; Mallucci C; Macarthur D; Jaspan T; Michalski A; Grundy RG;
Eur J Cancer; 2009 Jul; 45(10):1815-23. PubMed ID: 19427780
[TBL] [Abstract][Full Text] [Related]
8. Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocol.
Massimino M; Barretta F; Modena P; Johann P; Ferroli P; Antonelli M; Gandola L; Garrè ML; Bertin D; Mastronuzzi A; Mascarin M; Quaglietta L; Viscardi E; Sardi I; Ruggiero A; Boschetti L; Giagnacovo M; Biassoni V; Schiavello E; Chiapparini L; Erbetta A; Mussano A; Giussani C; Mura RM; Barra S; Scarzello G; Scimone G; Carai A; Giangaspero F; Buttarelli FR
Neuro Oncol; 2022 Mar; 24(3):467-479. PubMed ID: 34605902
[TBL] [Abstract][Full Text] [Related]
9. SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study.
Ritzmann TA; Chapman RJ; Kilday JP; Thorp N; Modena P; Dineen RA; Macarthur D; Mallucci C; Jaspan T; Pajtler KW; Giagnacovo M; Jacques TS; Paine SML; Ellison DW; Bouffet E; Grundy RG
Neuro Oncol; 2022 Jun; 24(6):936-948. PubMed ID: 35018471
[TBL] [Abstract][Full Text] [Related]
10. Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factors.
Zacharoulis S; Ji L; Pollack IF; Duffner P; Geyer R; Grill J; Schild S; Jaing TH; Massimino M; Finlay J; Sposto R
Pediatr Blood Cancer; 2008 Feb; 50(2):231-5. PubMed ID: 17610266
[TBL] [Abstract][Full Text] [Related]
11. Impact of radiation therapy and extent of resection for ependymoma in young children: A population-based study.
Snider CA; Yang K; Mack SC; Suh JH; Chao ST; Merchant TE; Murphy ES
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115718
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of H3K27me3 in children with ependymoma.
Han Z; Kang P; Zhang H; Liao Z; Li C; Gong J; Liu W; Tian Y
Pediatr Blood Cancer; 2020 Mar; 67(3):e28121. PubMed ID: 31850684
[TBL] [Abstract][Full Text] [Related]
13. Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma.
Merchant TE; Bendel AE; Sabin ND; Burger PC; Shaw DW; Chang E; Wu S; Zhou T; Eisenstat DD; Foreman NK; Fuller CE; Anderson ET; Hukin J; Lau CC; Pollack IF; Laningham FH; Lustig RH; Armstrong FD; Handler MH; Williams-Hughes C; Kessel S; Kocak M; Ellison DW; Ramaswamy V
J Clin Oncol; 2019 Apr; 37(12):974-983. PubMed ID: 30811284
[TBL] [Abstract][Full Text] [Related]
14. Analysis on therapeutic outcomes and prognostic factors of intracranial ependymoma: a report of 49 clinical cases in a single center.
Ye J; Zhu J; Yan J; Chen P; Wan Z; Chen F; Zhang L; Qian J; Luo C
Neurol Sci; 2015 Dec; 36(12):2253-61. PubMed ID: 26216494
[TBL] [Abstract][Full Text] [Related]
15. Molecular subgrouping of ependymoma across three anatomic sites and their prognostic implications.
Chinnam D; Gupta K; Kiran T; Saraswati A; Salunke P; Madan R; Kumar N; Radotra BD
Brain Tumor Pathol; 2022 Jul; 39(3):151-161. PubMed ID: 35348910
[TBL] [Abstract][Full Text] [Related]
16. Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival.
Marinoff AE; Ma C; Guo D; Snuderl M; Wright KD; Manley PE; Al-Sayegh H; Sinai CE; Ullrich NJ; Marcus K; Haas-Kogan D; Goumnerova L; London WB; Kieran MW; Chi SN; Fangusaro J; Bandopadhayay P
J Neurooncol; 2017 Oct; 135(1):201-211. PubMed ID: 28733870
[TBL] [Abstract][Full Text] [Related]
17. Local and systemic therapy of recurrent ependymoma in children and adolescents: short- and long-term results of the E-HIT-REZ 2005 study.
Adolph JE; Fleischhack G; Mikasch R; Zeller J; Warmuth-Metz M; Bison B; Mynarek M; Rutkowski S; Schüller U; von Hoff K; Obrecht D; Pietsch T; Pfister SM; Pajtler KW; Witt O; Witt H; Kortmann RD; Timmermann B; Krauß J; Frühwald MC; Faldum A; Kwiecien R; Bode U; Tippelt S
Neuro Oncol; 2021 Jun; 23(6):1012-1023. PubMed ID: 33331885
[TBL] [Abstract][Full Text] [Related]
18. The role of resection alone in select children with intracranial ependymoma: the Canadian Pediatric Brain Tumour Consortium experience.
Ailon T; Dunham C; Carret AS; Tabori U; Mcneely PD; Zelcer S; Wilson B; Lafay-Cousin L; Johnston D; Eisenstat DD; Silva M; Jabado N; Goddard KJ; Fryer C; Hendson G; Hawkins C; Dunn S; Yip S; Singhal A; Hukin J
Childs Nerv Syst; 2015 Jan; 31(1):57-65. PubMed ID: 25391979
[TBL] [Abstract][Full Text] [Related]
19. A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods.
de Sousa GR; Lira RCP; de Almeida Magalhães T; da Silva KR; Nagano LFP; Saggioro FP; Baroni M; Marie SKN; Oba-Shinjo SM; Brandelise S; de Paula Queiroz RG; Brassesco MS; Scrideli CA; Tone LG; Valera ET
J Mol Med (Berl); 2021 Aug; 99(8):1101-1113. PubMed ID: 33903940
[TBL] [Abstract][Full Text] [Related]
20. Review of ependymomas: assessment of consensus in pathological diagnosis and correlations with genetic profiles and outcome.
Sasaki A; Hirato J; Hirose T; Fukuoka K; Kanemura Y; Hashimoto N; Kodama Y; Ichimura K; Sakamoto H; Nishikawa R
Brain Tumor Pathol; 2019 Apr; 36(2):92-101. PubMed ID: 30929114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
